» Articles » PMID: 29588991

Early-onset Epileptic Encephalopathy and Severe Developmental Delay in an Association with De Novo Double Mutations in and

Abstract

Advance in the exome-wide sequencing analysis contributes to identifying hundreds of genes that are associated with early-onset epileptic encephalopathy and neurodevelopmental disorders. On the basis of massive sequencing data, functional interactions among different genes are suggested to explain the common molecular pathway underlying the pathogenic process of these disorders. However, the relevance of such interactions with the phenotypic severity or variety in an affected individual remains elusive. In this report, we present a 45-year-old woman with neurofibromatosis type 1 (NF1), infantile-onset epileptic encephalopathy, and severe developmental delay. Whole-exome sequencing identified de novo pathogenic mutations in and the Schaaf-Yang syndrome-associated gene, . Literature-curated interaction data predicted that NF1 and MAGEL2 proteins were closely connected in this network via their common interacting proteins. Direct conversion of fibroblasts into neurons in vitro showed that neuronal cells from 9 patients with NF1 expressed significantly lower levels of (54%, p = 0.0047) than those from healthy individuals. These data provide the first evidence that pathogenic mutations of deregulate the expression of other neurodevelopmental disease-associated genes. De novo mutations in multiple genes may lead to severe developmental phenotypes through their cumulative effects or synergistic interactions.

Citing Articles

MAGEL2 (patho-)physiology and Schaaf-Yang syndrome.

Schubert T, Schaaf C Dev Med Child Neurol. 2024; 67(1):35-48.

PMID: 38950199 PMC: 11625468. DOI: 10.1111/dmcn.16018.


Forskolin rapidly enhances neuron-like morphological change of directly induced-neuronal cells from neurofibromatosis type 1 patients.

Sagata N, Kano S, Ohgidani M, Inamine S, Sakai Y, Kato H Neuropsychopharmacol Rep. 2020; 40(4):396-400.

PMID: 33037790 PMC: 7722681. DOI: 10.1002/npr2.12144.


Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy.

Takata A, Nakashima M, Saitsu H, Mizuguchi T, Mitsuhashi S, Takahashi Y Nat Commun. 2019; 10(1):2506.

PMID: 31175295 PMC: 6555845. DOI: 10.1038/s41467-019-10482-9.

References
1.
Claes L, Ceulemans B, Audenaert D, Smets K, Lofgren A, Del-Favero J . De novo SCN1A mutations are a major cause of severe myoclonic epilepsy of infancy. Hum Mutat. 2003; 21(6):615-21. DOI: 10.1002/humu.10217. View

2.
Allen A, Cossette P, Delanty N, Eichler E, Goldstein D, Han Y . De novo mutations in epileptic encephalopathies. Nature. 2013; 501(7466):217-21. PMC: 3773011. DOI: 10.1038/nature12439. View

3.
van der Bruggen P, Traversari C, Chomez P, Lurquin C, De Plaen E, Van den Eynde B . A gene encoding an antigen recognized by cytolytic T lymphocytes on a human melanoma. Science. 1991; 254(5038):1643-7. DOI: 10.1126/science.1840703. View

4.
Matarazzo V, Muscatelli F . Natural breaking of the maternal silence at the mouse and human imprinted Prader-Willi locus: A whisper with functional consequences. Rare Dis. 2014; 1:e27228. PMC: 3978896. DOI: 10.4161/rdis.27228. View

5.
Garg S, Green J, Leadbitter K, Emsley R, Lehtonen A, Evans D . Neurofibromatosis type 1 and autism spectrum disorder. Pediatrics. 2013; 132(6):e1642-8. DOI: 10.1542/peds.2013-1868. View